Success Stories: EB-1A Petition Approved for Highly Cited Expert in Health Economics and Pharmacoeconomics
Client’s Testimonial:
“Thank you so much for sending the approval notice for my EB1A case. It has been a pleasure working with you throughout this process, and I truly appreciate your support.”
On June 3rd, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Scholar in the Field of Health Outcomes Research and Pharmacoeconomics (Approval Notice).
General Field: Health Outcomes Research and Pharmacoeconomics
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: Ethiopia
State of Residence at the Time of Filing: Ohio
Approval Notice Date: June 3rd, 2025
Processing Time: 7 months, 17 days (Premium Processing Requested)
Case Summary:
Our client has earned international recognition for his pioneering work at the intersection of epidemiology, health economics, and pharmacoeconomics. His research has advanced understanding in areas such as cardiovascular disease outcomes, chronic disease treatment effectiveness, and medication adherence, fields vital to improving global and national public health.
He has made original contributions of major significance, including:
o Conducting comprehensive evaluations of hypertension and cardiovascular outcomes,
o Investigating patient safety in low-income countries, and
o Exploring clinical outcomes in mental health disorders.
His research addresses some of the world’s most urgent healthcare challenges, such as predicting uncontrolled diabetes outcomes, assessing treatment effectiveness for chronic conditions, and improving quality of life for patients facing long-term illness.
In fact, our client is among the top 1% most highly cited authors publishing in medicine over the past eight years. His research has been cited 2307 times, and he holds an h-index of 24, placing him in the top 2% of medical researchers worldwide. This level of citation not only reflects academic prestige, but it also underscores the broad, practical impact of his work.
“It is clear that [client] stands at the top of his field, given his achievements in areas such as conducting comprehensive meta-analyses to evaluate antihypertensive medication adherence, assessing organ damage due to uncontrolled hypertension, and investigating the safety and effectiveness of antihypertensive drugs. Ensuring the continuation of [client]’s work is thus deeply important to both health outcomes research and pharmacoeconomics and the nation.”
Our client’s leadership extends beyond publication. He has:
● Authored 41 peer-reviewed journal articles (15 first-authored),
● Published 10 abstracts (8 first-authored), and
● Contributed 2 preprints, further disseminating knowledge to the research community.
In service to the field, he has also completed at least 20 peer reviews and served as both a guest editor and handling editor for respected academic journals.
Recognizing the exceptional nature of his career, the North America Immigration Law Group (NAILG) prepared and submitted our client’s EB-1A petition. By demonstrating his original contributions, leadership roles, and field-wide impact, NAILG successfully secured approval, affirming his standing as an individual of extraordinary ability.